Lee Chi-Wei, Chu Ming-Chia, Wu Han-Fang, Chung Yueh-Jung, Hsieh Tsung-Han, Chang Chieh-Yu, Lin Yen-Cheng, Lu Ting-Yi, Chang Ching-Hsiang, Chi Hsiang, Chang Hsun-Shuo, Chen Yih-Fung, Li Cheng-Ta, Lin Hui-Ching
Department and Institute of Physiology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Department of Optometry, Hsin-Sheng College of Medical Care and Management, Taoyuan, Taiwan.
Exp Neurol. 2023 Apr;362:114338. doi: 10.1016/j.expneurol.2023.114338. Epub 2023 Jan 27.
Treatment-resistant depression (TRD) is a condition wherein patients with depression fail to respond to antidepressant trials. A new form of repetitive transcranial magnetic stimulation (rTMS), called theta-burst stimulation (TBS), which includes intermittent theta-burst stimulation (iTBS) and continuous theta-burst stimulation (cTBS), is non-inferior to rTMS in TRD treatment. However, the mechanism of iTBS and cTBS underlying the treatment of TRD in the prefrontal cortex (PFC) remains unclear. Hence, we applied foot-shock stress as a traumatic event to develop a TRD rat model and investigated the different mechanisms of iTBS and cTBS. The iTBS and cTBS treatment were effective in depressive-like behavior and active coping behavior. The iTBS treatments improved impaired long-term potentiation and long-term depression (LTD), whereas the cTBS treatment only improved aberrant LTD. Moreover, the decrease in mature brain-derived neurotrophic factor (BDNF)-related protein levels were reversed by iTBS treatment. The decrease in proBDNF-related protein expression was improved by iTBS and cTBS treatment. Both iTBS and cTBS improved the decreased α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and downregulation of mammalian target of the rapamycin (mTOR) signaling pathway. The iTBS produces both excitatory and inhibitory synaptic effects, and the cTBS only produces inhibitory synaptic effects in the PFC.
难治性抑郁症(TRD)是一种抑郁症患者对抗抑郁试验无反应的病症。一种新的重复经颅磁刺激(rTMS)形式,称为theta爆发刺激(TBS),包括间歇性theta爆发刺激(iTBS)和连续性theta爆发刺激(cTBS),在TRD治疗中不劣于rTMS。然而,iTBS和cTBS在额叶前皮质(PFC)治疗TRD的潜在机制仍不清楚。因此,我们将足部电击应激作为创伤性事件来建立TRD大鼠模型,并研究iTBS和cTBS的不同机制。iTBS和cTBS治疗对抑郁样行为和主动应对行为有效。iTBS治疗改善了受损的长时程增强和长时程抑制(LTD),而cTBS治疗仅改善了异常的LTD。此外,iTBS治疗逆转了成熟脑源性神经营养因子(BDNF)相关蛋白水平的降低。iTBS和cTBS治疗改善了前体BDNF相关蛋白表达的降低。iTBS和cTBS均改善了α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体的减少以及雷帕霉素哺乳动物靶标(mTOR)信号通路的下调。iTBS在PFC中产生兴奋性和抑制性突触效应,而cTBS仅产生抑制性突触效应。